BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
BusinessEli Lilly takes aim at illicit market for its experimental weight-loss drugWorldPune Ganeshotsav 2026: Ganpati Visarjan Procession Runs For 33 Hours 33 MinutesWorldMumbai: MNS Chief Raj Thackeray Announces ‘Jan Morcha’ With Uddhav Sena On October 4 Against Gyanesh Kumar Over SIRWorldParul University Marks World Peace Day With 'Choose Your Response' Initiative, Engaging 5,000 Students In Conscious Decision-MakingWorldRajkummar Rao And Wamiqa Gabbi Starrer Prahaar Trailer To Be Launched At Mumbai's CSMT Station - Deets Inside
Business/Source-attributed reporting
Business DESK

Eli Lilly takes aim at illicit market for its experimental weight-loss drug

The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.

Published Aug 15, 2026 · 11:22 PMOriginal source: CBS2 reads
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
ORIGINAL SOURCE

CBS

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗
RELATED COVERAGE

More from this desk.